Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04495179
Title A Study of AZD4635 With Durvalumab and With Cabazitaxel and Durvalumab in Patients With mCRPC. (AARDVARC)
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors AstraZeneca

prostate adenocarcinoma


AZD4635 + Durvalumab

AZD4635 + Cabazitaxel + Durvalumab

Age Groups: adult | senior
Covered Countries USA | FRA | ESP | BEL

No variant requirements are available.